EVOFEM BIOSCIENCES, INC. (EVFM) Free cash flow 2016–2025
EVOFEM BIOSCIENCES, INC. (EVFM) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$2.0MFY2025 · since FY2016: -$16.8M → -$2.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$2.0M | +48.8% |
| FY2024 | -$3.9M | +56.5% |
| FY2023 | -$9.0M | +87.3% |
| FY2022 | -$70.8M | +52.7% |
| FY2021 | -$149.6M | -39.7% |
| FY2020 | -$107.1M | -93.8% |
| FY2019 | -$55.3M | +2.2% |
| FY2018 | -$56.5M | -193.6% |
| FY2017 | -$19.2M | -14.9% |
| FY2016 | -$16.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More EVFM financial trends
EVFM RevenueEVFM Net incomeEVFM Net marginEVFM Gross profitEVFM Gross marginEVFM Operating incomeEVFM Operating marginEVFM Operating cash flowEVFM Capital expendituresEVFM Return on equityEVFM Stock buybacksEVFM Dividends paidEVFM Total assetsEVFM Total liabilitiesEVFM Shareholders’ equityEVFM overview →